


全文预览已结束
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
XXXXX DOB: MMM.YYYY Gender: MaleNative place: XXXXX city, XXXXX ProvinceMajor: Clinical Medicine & Molecular OncologyPhone: 139XXXXXXXXEmail: XXXXXXXXObjectiveSenior CRA or CRA II (located in Shanghai) SummaryCertified CRA of ACRP, March 2011May 31, 2013;More than two years experiences as a Clinical Research Associate;In-depth knowledge of Helsinki Declaration, ICH-GCP Guidelines and SOPs;Self-study of FDA CFR online; Therapeutic areas include cancer, endocrine and cardiovascular diseases;Good understanding of medical terminology;Familiarity with EDC, IVRS/IWRS and central laboratory procedures;Excellent interpersonal skills and fast prioritization of tasks;Strong sense of self-discipline;Good spirit of team work;Fluent in American English and Mandarin;Enjoy travelling.Education20052008, Master; Biomedical researches on Molecular Oncology; Fudan University, Shanghai, China 20002005, Bachelor; Clinical Medicine; University of South ChinaWork ExperienceI. Mar/2011-June/2011, Research Assistant at Buck Institute for Research on Aging Job Description: Assist in the design, preparation, implementation of experiments, and analysis of the results to explore the compounds that can extend lifespan of animal models and their corresponding molecular mechanisms, as well as to find new strategies for the treatment of neuron degenerative diseases such as Alzheimers disease and Parkinsons disease; Acquired a well understanding of American culture and improved communication skills in English through this job. II. Sep/2010-Mar/2011, Member of Association of Clinical Research Professional (ACRP)(1) Systematically learning of ICH-E6, ICH-E8, ICH-E2A and ACRP recommended documents, such as Guide to Clinical Trials;(2) Passed the examination of Certified Clinical Research Associate (CCRA);(3) Study the clinical trial regulations of Food and Drug Administration (FDA);(4) Involved in the discussion of monitoring and management of clinical trials in the e-Forum of ACRP, built the knowledge on the status quo of clinical trial industry in US. III. Apr/2009-Aug/2010, Contract CRA in Omnicare Clinical Research (China), based in Boehringer-Ingelheim (Shanghai)Main Responsibilities: (1) Select appropriate sites to conduct clinical trials;(2) Negotiate with principal investigators to conclude clinical trial contracts;(3) Prepare IRB/IEC submission documents;(4) Conduct initiation meeting to start a trial within required timeline;(5) Perform periodic monitoring visits to discuss recruitment with investigators, to verify trial data against source documents, to coordinate with the resolution of queries, to facilitate the report of SAE, to check records regarding investigational products, to assist with the arrangement of essential documents, and ultimately, to protect the safety, rights and well-being of subjects and to keep high quality as well as good progress of clinical trials;(6) Make close out visits according to SOP, ICH-GCP and applicable regulations; (7) Liaison between site and sponsor for other logistic affairs;(8) Write relevant reports according to SOP. Achievements:(1) Responsible for monitoring 2 trials, including 7 sites and 71 ongoing subjects simultaneously; this was the highest workload among all CRAs in Boehringer-Ingelheim. Moreover, the recruitment was faster than most colleagues sites, RDC verification rate was kept near 80%, and all trial related documents were filed well in sites;(2) 4 subjects were recruited within one month after initiation visit of a global phase III trial. This recruitment rate was 7 times higher than the average recruitment speed that was 2 subjects every 4 months;(3) 43 eligible subjects were enrolled within two months for a global phase IV trial. This timeline was more than two months ahead of global plan; (4) 25 subjects were recruited for a phase I clinical trial within one month, all EDC queries were resolved on time, all essential documents were filed well and samples were sent to UK within schedule. IV.Jul/2008-Mar/2009, CRA in Shanghai Zhangjiang Biotechnology Co. Ltd. Main jobs and accomplishments:(1) Involved in the monitoring of one phase I and one phase III trial of anti-tumor drugs;(2) Presided over one initiating meeting of a phase III trial. Highly praised by investigators for outstanding presentation skills and close attention to details;(3) Periodic monitoring visits for 6 sites. Enhance the recruitment from 12 subjects per month to 16;(4) Wrote research summary for investigational products. Acquired a broad knowledge on anti-tumor products;(5) Assist in the organization of an investigators meeting; (6) Edited slides for one investigators meeting.Trainee Experience(1) Apr/2010, CRA Essential Skills Training Courses provided by Senior Training Director Mr. Iain Searle of Omnicare Clinical Research. Main topics include the responsibilities and procedures about four types of monitoring visits: pre-trial visit, initiation visit, periodic monitoring visit and c
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025浙江嘉兴南湖嘉禾商务咨询有限公司招聘3人笔试参考题库附带答案详解
- 2025河北保定钞票纸业有限公司人员招聘29人笔试参考题库附带答案详解
- 2025广东中山市三角镇资产经营有限公司招聘管理人员1人笔试参考题库附带答案详解
- 2025年开封市文化旅游投资集团有限公司招聘5人笔试参考题库附带答案详解
- 2025年南京地铁运营有限责任公司秋季招聘笔试参考题库附带答案详解
- 2025天津市今晚网络信息技术股份有限公司招聘40人笔试参考题库附带答案详解
- 2025中国机械工业集团有限公司(国机集团)社会招聘19人笔试参考题库附带答案详解
- 地铁扶梯安全培训课件
- 地铁安全知识培训课件
- 地质队安全培训暨宣誓课件
- 恒瑞医药简介课件
- 甲午中日战争情景剧
- 石油行业安全培训课件
- 国开电大组织行为学任务四调查报告
- 事业单位医学基础知识名词解释
- 施工现场安全监理危险源清单一览表
- GB/T 233-2000金属材料顶锻试验方法
- FZ/T 74003-2014击剑服
- 颈椎DR摄影技术-
- 功能材料概论-课件
- 一点儿有点儿课件
评论
0/150
提交评论